T1	Participants 5 43	chemotherapy of advanced breast cancer
T2	Participants 61 135	first 600 cases in a cooperative programme to carry out a systematic study
T3	Participants 253 294	methodic study of advanced breast cancers
T4	Participants 362 421	departments of medicine in eight French anticancer centres.
T5	Participants 568 580	603 patients
T6	Participants 659 858	interrupted doses of chemotherapy which consisted of vincristine associated for the one part with cyclophosphamide and 5-fluoro-uracil and on the other hand with doxorubicine or/and with methotrexate
T7	Participants 1103 1122	series of 240 cases
